BCRX Biocryst Pharmaceuticals Inc.
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
- 0 P/E
- 5.4 P/S
- 6.46 P/B
- -0.744 EPS
- -156.52% Cash ROIC
- 1.59 Cash Ratio
- 0 / 0% Dividend
- 1.55M Avg. Vol.
- 45.14M Shares
- 95.1M Market Cap.
BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer modeling to develop new therapeutic candidates. The com...
Openglobe - May 30, 2013
NIS - May 28, 2013
REM - May 28, 2013
eStocksDaily - May 28, 2013
PR Carbon (press release) - May 30, 2013
Marketwire (press release) - May 30, 2013
Sacramento Bee - Jun 13, 2013
Reuters Key Development - Nov 30, 2012
Reuters Key Development - Oct 18, 2012
Reuters Key Development - Jul 24, 2012